NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.043 HKD | 0.00% |
|
-15.69% | -14.00% |
| 06-24 | New Ray Medicine Shareholders to Vote July 16 on Purchase Contract | MT |
| 05-17 | New Ray Medicine International Unit to Buy 16% Stake in Pharmaceutical Firm | MT |
New Ray Medicine International Holding Ltd is a company principally engaged in the distribution and trading of pharmaceutical products. The Company operates its businesses through two segments. Distribution and Trading of Pharmaceutical Products segment is mainly engaged in distribution and trading of injection drugs. Provision of Marketing and Promotion Services segment is mainly involved in provision of marketing and promotion services of drugs and chemical reagents. The Company mainly operates its businesses in the domestic market.
Sector
Drug Retailers
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.00% | 9.21M | |
| -53.68% | 10.44B | |
| -45.65% | 8.68B | |
| -26.18% | 6.45B | |
| -7.49% | 5.98B | |
| +85.61% | 4.91B | |
| -3.36% | 4.57B | |
| +5.73% | 4.49B | |
| -26.42% | 4.1B | |
| -18.65% | 2.58B |
- Stock Market
- Equities
- 6108 Stock
- News New Ray Medicine International Holding Limited
- New Ray Medicine's 2022 Loss Balloons as Revenue Slumps 73%
